| Schedule of Assets and Liabilities Measured at Fair value |
The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis as of June 30, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | Total | | Quoted
prices in
active
markets
(Level 1) | | Significant
other
observable
inputs
(Level 2) | | Significant
unobservable
inputs
(Level 3) | | (in thousands) | | Assets: | | | | | | | | | Deferred compensation plan investments, current and non-current portion | $ | 37,642 | | | $ | 37,642 | | | $ | — | | | $ | — | | | | | | | | | | | Interest rate swap agreement | 239 | | | — | | | 239 | | | — | | | Foreign currency hedge | 11 | | | — | | | 11 | | | — | | | Total assets at fair value | $ | 37,892 | | | $ | 37,642 | | | $ | 250 | | | $ | — | | | Liabilities: | | | | | | | | | Deferred compensation plan investments, current and non-current portion | $ | 37,642 | | | $ | 37,642 | | | $ | — | | | $ | — | | | Forward foreign currency exchange contracts | 3 | | | — | | | 3 | | | — | | | | | | | | | | | Liability for contingent consideration, current and non-current | 28,150 | | | — | | | — | | | 28,150 | | | Total liabilities at fair value | $ | 65,795 | | | $ | 37,642 | | | $ | 3 | | | $ | 28,150 | |
The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis as of June 30, 2025:
| | | | | | | | | | | | | | | | | | | | | | | | | Total | | Quoted
prices in
active
markets
(Level 1) | | Significant
other
observable
inputs
(Level 2) | | Significant
unobservable
inputs
(Level 3) | | (in thousands) | | Assets: | | | | | | | | | Deferred compensation plan investments, current and non-current portion | $ | 31,887 | | | $ | 31,887 | | | $ | — | | | $ | — | | | Forward foreign currency exchange contracts | 15 | | | — | | | $ | 15 | | | | | Interest rate swap agreement | 680 | | | — | | | 680 | | | — | | | | | | | | | | | Total assets at fair value | $ | 32,582 | | | $ | 31,887 | | | $ | 695 | | | $ | — | | | Liabilities: | | | | | | | | | Deferred compensation plan investments, current and non-current portion | $ | 31,887 | | | $ | 31,887 | | | $ | — | | | $ | — | | | | | | | | | | | Foreign currency hedge | 290 | | | — | | | 290 | | | — | | | Liability for contingent consideration, current and non-current | 19,100 | | | — | | | — | | | 19,100 | | | Total liabilities at fair value | $ | 51,277 | | | $ | 31,887 | | | $ | 290 | | | $ | 19,100 | |
|
| Schedule of Changes in Fair Value of Contingent Considerations |
The following tables represent the Company's contingent consideration liabilities at June 30, 2026 and 2025: | | | | | | | | | | | | | | | | | | | Fiscal Year Ended June 30, 2026 | | Specialty Technology Solutions | | Intelisys & Advisory | | Total | | (in thousands) | | Fair value at beginning of period | $ | 6,660 | | | $ | 12,440 | | | $ | 19,100 | | | Issuance of contingent consideration | 9,352 | | | — | | | 9,352 | | | Payments | (1,375) | | | — | | | (1,375) | | | | | | | | | Change in valuation | 1,243 | | | (170) | | | 1,073 | | | | | | | | | Fair value at end of period | $ | 15,880 | | | $ | 12,270 | | | $ | 28,150 | | | | | | | | | Fiscal year ended June 30, 2025 | | Specialty Technology Solutions | | Intelisys & Advisory | | Total | | (in thousands) | | Fair value at beginning of period | $ | — | | | $ | — | | | $ | — | | | Issuance of contingent consideration | 7,500 | | | 9,700 | | | 17,200 | | | | | | | | | | | | | | | Change in valuation | (840) | | | 2,740 | | | 1,900 | | | | | | | | | Fair value at end of period | $ | 6,660 | | | $ | 12,440 | | | $ | 19,100 | |
Significant observable inputs used in recurring Level 3 fair value measurements for the Company's contingent consideration liabilities by segment related to acquisitions at June 30, 2026 and June 30, 2025 were as follows.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Significant observable inputs | | Significant observable inputs | | | June 30, 2026 | | June 30, 2025 | | Acquisition | | Specialty Technology Solutions | | Intelisys & Advisory | | Specialty Technology Solutions | | Intelisys & Advisory | | Weighted-average payor credit spread | | 1.32 | % | | 1.32 | % | | 1.80 | % | | 1.80 | % | | Weighted-average adjusted EBITDA risk premium | | 12.30 | % | | 12.50 | % | | 15.30 | % | | 12.70 | % | | Adjusted EBITDA volatility | | 60.00 | % | | 50.00 | % | | — | | | 40.00 | % |
|